Except for the endometrial carcinoma, ovarian cancer, and colon carcinoma [14], RPLP0, as a vital member of the RPLP family, is also upregulated in acute myeloid leukemia [31], clear cell renal cell carcinoma [32], and breast cancer [33]. Here, RPLP0 is linked to breast cancer.